The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Using immunopaths to image residual disease
Ola Landgren
• 15 Sep 2019
Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into immunopaths and describes the method by which he was successful in imaging potential residual disease that would not otherwise have been visible using blood tests or biopsies. This interview was recorded at the international myeloma workshop (IMW) 2019, in Boston, MA.
